Soberana 01: Novel clinical trials of vaccine with subjects recovered from COVID-19
Although the hopes of Cuban science to defeat COVID-19 appear to be centered on the remarkable progress of studies of the Soberana 02 candidate vaccine, the truth is that clinical trials to demonstrate the safety and immunogenicity of Soberana 01 are also showing promising results.
- Written by Granma
- Category: Health
- Hits: 1719
The General Director of the Finlay Institute of Vaccines, Vicente Vérez Bencomo, announced in a press conference with foreign agencies accredited in Havana, that Cuba is preparing the capacities to produce one hundred million doses of the vaccine Soberana 02 against the Covid-19.
